Catalyst Wire Dossier Catalyst Wire Dossier

Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)

emtricitabine/tenofovir disoproxil fumarate · Gilead Sciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy Participants [Phase 1]

See pricing